Wealth Enhancement Advisory Services’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$130K Buy
37,861
+12,711
+51% +$40.7K ﹤0.01% 3261
2025
Q4
$64.1K Sell
25,150
-2,808
-10% -$6.5K ﹤0.01% 3506
2025
Q3
$60.9K Buy
27,958
+3,223
+13% +$7.61K ﹤0.01% 3403
2025
Q2
$43.3K Sell
24,735
-2,716
-10% -$6.76K ﹤0.01% 3244
2025
Q1
$91.4K Buy
27,451
+8,713
+46% +$44.9K ﹤0.01% 2778
2024
Q4
$139K Sell
18,738
-5,671
-23% -$52.6K ﹤0.01% 2752
2024
Q3
$229K Sell
24,409
-62
-0.3% -$587 ﹤0.01% 2362
2024
Q2
$196K Buy
24,471
+3,565
+17% +$38.2K ﹤0.01% 2306
2024
Q1
$310K Buy
20,906
+2,987
+17% +$34.8K ﹤0.01% 1901
2023
Q4
$146K Buy
17,919
+281
+2% +$1.47K ﹤0.01% 2134
2023
Q3
$80.3K Buy
+17,638
New +$115K ﹤0.01% 2126

Other funds holding IOVA